nach oben

Erschienen in:

26.09.2024 | Public Health Policy (SS Virani and D Mahtta, Section Editors)

The Price We Pay for Progression in Shock Care: Economic Burden, Accessibility, and Adoption of Shock-Teams and Mechanical Circulatory Support Devices

verfasst von: Saraschandra Vallabhajosyula, Shashank S. Sinha, Ajar Kochar, Mohit Pahuja, Frank J. Amico Jr, Navin K. Kapur

Erschienen in: Current Cardiology Reports | Ausgabe 10/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Cardiogenic shock (CS) is associated with high in-hospital and long-term mortality and morbidity that results in significant socio-economic impact. Due to the high costs associated with CS care, it is important to define the short- and long-term burden of this disease state on resources and review strategies to mitigate these.

Recent Findings

In recent times, the focus on CS continues to be on improving short-term outcomes, but there has been increasing emphasis on the long-term morbidity. In this review we discuss the long-term outcomes of CS and the role of hospital-level and system-level disparities in perpetuating this. We discuss mitigation strategies including developing evidence-based protocols and systems of care, improvement in risk stratification and evaluation of futility of care, all of which address the economic burden of CS.

Summary

CS continues to remain the pre-eminent challenge in acute cardiovascular care, and a combination of multi-pronged strategies are needed to improve outcomes in this population.

Vallabhajosyula S, Bhopalwala HM, Sundaragiri PR, Dewaswala N, Cheungpasitporn W, Doshi R, et al. Cardiogenic shock complicating non-ST-segment elevation myocardial infarction: an 18-year study. Am Heart J. 2022;244:54–65. https://doi.org/10.1016/j.ahj.2021.11.002.CrossRefPubMed

Vallabhajosyula S, Dewaswala N, Sundaragiri PR, Bhopalwala HM, Cheungpasitporn W, Doshi R, et al. Cardiogenic shock complicating ST-Segment Elevation myocardial infarction: an 18-Year analysis of temporal trends, Epidemiology, Management, and outcomes. Shock. 2022;57(3):360–9. https://doi.org/10.1097/shk.0000000000001895.CrossRefPubMed

Shankar A, Gurumurthy G, Sridharan L, Gupta D, Nicholson WJ, Jaber WA, et al. A clinical update on Vasoactive Medication in the management of cardiogenic shock. Clin Med Insights Cardiol. 2022;16:11795468221075064. https://doi.org/10.1177/11795468221075064.CrossRefPubMedPubMedCentral

Vallabhajosyula S, Dunlay Shannon M, Prasad A, Kashani K, Sakhuja A, Gersh Bernard J, et al. Acute Noncardiac Organ failure in Acute Myocardial Infarction with cardiogenic shock. J Am Coll Cardiol. 2019;73(14):1781–91. https://doi.org/10.1016/j.jacc.2019.01.053.CrossRefPubMed

Hernandez-Montfort J, Kanwar M, Sinha SS, Garan AR, Blumer V, Kataria R, et al. Clinical presentation and In-Hospital trajectory of heart failure and cardiogenic shock. JACC Heart Fail. 2023;11(2):176–87. https://doi.org/10.1016/j.jchf.2022.10.002.CrossRefPubMed

Vallabhajosyula S, Arora S, Lahewala S, Kumar V, Shantha GPS, Jentzer JC, et al. Temporary Mechanical Circulatory support for refractory cardiogenic shock before left ventricular assist device surgery. J Am Heart Assoc. 2018;7(22):e010193. https://doi.org/10.1161/jaha.118.010193.CrossRefPubMedPubMedCentral

Vallabhajosyula S, Verghese D, Henry TD, Katz JN, Nicholson WJ, Jaber WA et al. Contemporary Management of Concomitant Cardiac Arrest and Cardiogenic Shock Complicating Myocardial Infarction. Mayo Clin Proc. 2022;97(12):2333-54. https://doi.org/10.1016/j.mayocp.2022.06.027.

Vallabhajosyula S, Payne SR, Jentzer JC, Sangaralingham LR, Kashani K, Shah ND et al. Use of Post-Acute Care Services and Readmissions After Acute Myocardial Infarction Complicated by Cardiac Arrest and Cardiogenic Shock. Mayo Clinic proceedings Innovations, quality & outcomes. 2021;5(2):320-9. https://doi.org/10.1016/j.mayocpiqo.2020.12.006.

Vallabhajosyula S, Payne SR, Jentzer JC, Sangaralingham LR, Yao X, Kashani K, et al. Long-term outcomes of Acute myocardial infarction with concomitant cardiogenic shock and cardiac arrest. Am J Cardiol. 2020;133:15–22. https://doi.org/10.1016/j.amjcard.2020.07.044.CrossRefPubMed

10.

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI strategies in patients with Acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419–32. https://doi.org/10.1056/NEJMoa1710261.CrossRefPubMed

11.

Patlolla SH, Kanwar A, Cheungpasitporn W, Doshi RP, Stulak JM, Holmes DR Jr., et al. Temporal trends, clinical characteristics, and outcomes of Emergent Coronary Artery Bypass Grafting for Acute myocardial infarction in the United States. J Am Heart Assoc. 2021;10(15):e020517. https://doi.org/10.1161/jaha.120.020517.CrossRefPubMedPubMedCentral

12.

Jentzer JC, Ahmed AM, Vallabhajosyula S, Burstein B, Tabi M, Barsness GW, et al. Shock in the cardiac intensive care unit: changes in epidemiology and prognosis over time. Am Heart J. 2021;232:94–104. https://doi.org/10.1016/j.ahj.2020.10.054.CrossRefPubMed

13.

Sandoval Y, Basir MB, Lemor A, Lichaa H, Alasnag M, Dupont A, et al. Optimal large-bore femoral Access, Indwelling Device Management, and Vascular Closure for Percutaneous Mechanical Circulatory support. Am J Cardiol. 2023;206:262–76. https://doi.org/10.1016/j.amjcard.2023.08.024.CrossRefPubMed

14.

Vallabhajosyula S, Dunlay SM, Kashani K, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, et al. Temporal trends and outcomes of prolonged invasive mechanical ventilation and tracheostomy use in acute myocardial infarction with cardiogenic shock in the United States. Int J Cardiol. 2019;285:6–10. https://doi.org/10.1016/j.ijcard.2019.03.008.CrossRefPubMed

15.

Vallabhajosyula S, Shankar A, Patlolla SH, Prasad A, Bell MR, Jentzer JC, et al. Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shock. ESC Heart Fail. 2020;7(3):1234–45. https://doi.org/10.1002/ehf2.12652.CrossRefPubMedPubMedCentral

16.

Papolos AI, Kenigsberg BB, Berg DD, Alviar CL, Bohula E, Burke JA, et al. Management and outcomes of cardiogenic shock in Cardiac ICUs with Versus without Shock teams. J Am Coll Cardiol. 2021;78(13):1309–17. https://doi.org/10.1016/j.jacc.2021.07.044.CrossRefPubMed

17.

Bhat AG, van Diepen S, Katz JN, Islam A, Tehrani BN, Truesdell AG, et al. A Comprehensive Appraisal of Risk Prediction models for cardiogenic shock. Shock. 2022;57(5):617–29. https://doi.org/10.1097/shk.0000000000001921.CrossRefPubMed

18.

Vallabhajosyula S, Trials, Tribunals, Opportunities in Cardiogenic Shock Research. JACC Cardiovasc Interv. 2022;15(3):305–7. https://doi.org/10.1016/j.jcin.2021.12.016.CrossRefPubMed

19.

Sinha SS, Rosner CM, Tehrani BN, Maini A, Truesdell AG, Lee SB, et al. Cardiogenic shock from heart failure Versus Acute myocardial infarction: clinical characteristics, Hospital Course, and 1-Year outcomes. Circ Heart Fail. 2022;15(6):e009279. https://doi.org/10.1161/circheartfailure.121.009279.CrossRefPubMedPubMedCentral

20.

Heidenreich PA, Fonarow GC, Opsha Y, Sandhu AT, Sweitzer NK, Warraich HJ. Economic issues in Heart failure in the United States. J Card Fail. 2022;28(3):453–66. https://doi.org/10.1016/j.cardfail.2021.12.017.CrossRefPubMedPubMedCentral

21.

Khan SU, Khan MZ, Alkhouli M. Trends of Clinical outcomes and Health Care Resource Use in Heart failure in the United States. J Am Heart Assoc. 2020;9(14):e016782. https://doi.org/10.1161/jaha.120.016782.CrossRefPubMedPubMedCentral

22.

Yandrapalli S, Sanaani A, Harikrishnan P, Aronow WS, Frishman WH, Lanier GM, et al. Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes. Am Heart J. 2019;213:18–29. https://doi.org/10.1016/j.ahj.2019.03.015.CrossRefPubMed

23.

Collado E, Luiso D, Ariza-Solé A, Lorente V, Sánchez-Salado JC, Moreno R, et al. Hospitalization-related economic impact of patients with cardiogenic shock in a high-complexity reference centre. Eur Heart J Acute Cardiovasc Care. 2021;10(1):50–3. https://doi.org/10.1093/ehjacc/zuaa003.CrossRefPubMed

24.

Harjola VP, Costa S, Sund R, Ylikangas S, Siirilä-Waris K, Melin J, et al. The type of acute heart failure and the costs of hospitalization. Int J Cardiol. 2010;145(1):103–5. https://doi.org/10.1016/j.ijcard.2009.05.058.CrossRefPubMed

25.

Kilic A, Mathier MA, Hickey GW, Sultan I, Morell VO, Mulukutla SR, et al. Evolving trends in Adult Heart Transplant with the 2018 heart allocation policy change. JAMA Cardiol. 2021;6(2):159–67. https://doi.org/10.1001/jamacardio.2020.4909.CrossRefPubMed

26.

Parlow S, Fernando SM, Pugliese M, Qureshi D, Talarico R, Sterling LH, et al. Resource utilization and costs Associated with cardiogenic shock complicating myocardial infarction. JACC: Adv. 2024;3(8):101047. https://doi.org/10.1016/j.jacadv.2024.101047.CrossRefPubMed

27.

Schuster A, Faulkner M, Zeymer U, Ouarrak T, Eitel I, Desch S, et al. Economic implications of intra-aortic balloon support for myocardial infarction with cardiogenic shock: an analysis from the IABP-SHOCK II-trial. Clin Res Cardiol. 2015;104(7):566–73. https://doi.org/10.1007/s00392-015-0819-2.CrossRefPubMed

28.

Fernando SM, Qureshi D, Tanuseputro P, Talarico R, Hibbert B, Mathew R, et al. Long-term mortality and costs following use of Impella^® for mechanical circulatory support: a population-based cohort study. Can J Anaesth. 2020;67(12):1728–37. https://doi.org/10.1007/s12630-020-01755-9.CrossRefPubMed

29.

Miller PE, Bromfield SG, Ma Q, Crawford G, Whitney J, DeVries A, et al. Clinical outcomes and cost Associated with an intravascular Microaxial Left Ventricular assist device vs intra-aortic balloon pump in patients presenting with Acute myocardial infarction complicated by cardiogenic shock. JAMA Intern Med. 2022;182(9):926–33. https://doi.org/10.1001/jamainternmed.2022.2735.CrossRefPubMedPubMedCentral

30.

Chung M, Zhao Y, Strom JB, Shen C, Yeh RW. Extracorporeal membrane oxygenation use in cardiogenic shock: impact of age on In-Hospital mortality, length of Stay, and costs. Crit Care Med. 2019;47(3):e214–21. https://doi.org/10.1097/ccm.0000000000003631.CrossRefPubMedPubMedCentral

31.

Jäämaa-Holmberg S, Salmela B, Suojaranta R, Lemström KB, Lommi J. Cost-utility of venoarterial extracorporeal membrane oxygenation in cardiogenic shock and cardiac arrest. Eur Heart J Acute Cardiovasc Care. 2020;9(4):333–41. https://doi.org/10.1177/2048872619900090.CrossRefPubMed

32.

Vetrovec GW, Lim MJ, Needham KA. Cost savings for pVAD compared to ECMO in the management of acute myocardial infarction complicated by cardiogenic shock: an episode-of-care analysis. Catheter Cardiovasc Interv. 2021;98(4):703–10. https://doi.org/10.1002/ccd.29181.CrossRefPubMed

33.

Dhamija A, Kakuturu J, Schauble D, Hayanga HK, Jacobs JP, Badhwar V, et al. Outcome and cost of nurse-led vs perfusionist-led extracorporeal membrane oxygenation. Ann Thorac Surg. 2022;113(4):1127–34. https://doi.org/10.1016/j.athoracsur.2021.04.095.CrossRefPubMed

34.

Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, et al. Left ventricular unloading is Associated with Lower Mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an International, Multicenter Cohort Study. Circulation. 2020;142(22):2095–106. https://doi.org/10.1161/circulationaha.120.048792.CrossRefPubMedPubMedCentral

35.

Bansal A, Belford PM, Truesdell AG, Sinha SS, Zhao DX, Vallabhajosyula S. Meta-analysis on left ventricular unloading with Impella in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation. Am J Cardiol. 2023;193:52–4. https://doi.org/10.1016/j.amjcard.2023.01.053.CrossRefPubMed

36.

Gandhi KD, Moras EC, Niroula S, Lopez PD, Aggarwal D, Bhatia K, et al. Left ventricular unloading with Impella Versus IABP in patients with VA-ECMO: a systematic review and Meta-analysis. Am J Cardiol. 2023;208:53–9. https://doi.org/10.1016/j.amjcard.2023.09.023.CrossRefPubMed

37.

Kochar A, Vallabhajosyula S, John K, Sinha SS, Esposito M, Pahuja M, et al. Factors associated with Acute Limb Ischemia in cardiogenic shock and downstream clinical outcomes: insights from the cardiogenic shock Working Group. J Heart Lung Transpl. 2024. https://doi.org/10.1016/j.healun.2024.06.012.CrossRef

38.

Vallabhajosyula S, Ahmad K. The price we pay. JACC: Adv. 2024;3(8):101048. https://doi.org/10.1016/j.jacadv.2024.101048.CrossRefPubMed

39.

Atti V, Patel NJ, Kumar V, Tripathi B, Basir MB, Voeltz M, et al. Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock. Catheter Cardiovasc Interv. 2019;94(2):E67–77. https://doi.org/10.1002/ccd.28161.CrossRefPubMed

40.

Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, et al. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379(18):1699–710. https://doi.org/10.1056/NEJMoa1808788.CrossRefPubMed

41.

Shah M, Patel B, Tripathi B, Agarwal M, Patnaik S, Ram P, et al. Hospital mortality and thirty day readmission among patients with non-acute myocardial infarction related cardiogenic shock. Int J Cardiol. 2018;270:60–7. https://doi.org/10.1016/j.ijcard.2018.06.036.CrossRefPubMed

42.

Kuchtaruk AA, Sparrow RT, Azzalini L, García S, Villablanca PA, Jneid H, et al. Unplanned readmissions after Impella mechanical circulatory support. Int J Cardiol. 2023;379:48–59. https://doi.org/10.1016/j.ijcard.2023.03.013.CrossRefPubMed

43.

Nuqali A, Goyal A, Acharya P, Mastoris I, Dalia T, Chan WC, et al. Thirty-day readmissions among patients with cardiogenic shock who underwent extracorporeal membrane oxygenation support in the United States: insights from the nationwide readmissions database. Am Heart J Plus. 2022;13:100076. https://doi.org/10.1016/j.ahjo.2021.100076.CrossRefPubMed

44.

Scotti DJ, Gregory DA, Schreiber TL, Shroff A, Buck DR. Operational implications of utilizing 2 Advanced technologies for rendering short-term hemodynamic support to patients presenting with cardiogenic shock: a View through the Lens of Hospital Readmissions. Manag Care. 2015;24(5):38–44. 6.PubMed

45.

Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, et al. Post-hospital outcomes of patients with Acute Myocardial Infarction with cardiogenic shock: findings from the NCDR. J Am Coll Cardiol. 2016;67(7):739–47. https://doi.org/10.1016/j.jacc.2015.11.048.CrossRefPubMed

46.

Sterling LH, Fernando SM, Talarico R, Qureshi D, van Diepen S, Herridge MS, et al. Long-term outcomes of cardiogenic shock complicating myocardial infarction. J Am Coll Cardiol. 2023;82(10):985–95. https://doi.org/10.1016/j.jacc.2023.06.026.CrossRefPubMed

47.

Bansal M, Mehta A, Balakrishna AM, Saad M, Ventetuolo CE, Roswell RO et al. Race, ethnicity, and gender disparities in Acute myocardial infarction. Crit Care Clin. https://doi.org/10.1016/j.ccc.2024.05.005.

48.

Vallabhajosyula S, Verghese D, Desai VK, Sundaragiri PR, Miller VM. Sex differences in acute cardiovascular care: a review and needs assessment. Cardiovasc Res. 2022;118(3):667–85. https://doi.org/10.1093/cvr/cvab063.CrossRefPubMed

49.

Ton VK, Kanwar MK, Li B, Blumer V, Li S, Zweck E, et al. Impact of female sex on cardiogenic shock outcomes: a cardiogenic shock Working Group Report. JACC Heart Fail. 2023;11(12):1742–53. https://doi.org/10.1016/j.jchf.2023.09.025.CrossRefPubMed

50.

Vallabhajosyula S, Vallabhajosyula S, Dunlay SM, Hayes SN, Best PJM, Brenes-Salazar JA et al. Sex and Gender Disparities in the Management and Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in Older Adults. Mayo Clin Proc. 2020;95(9):1916-27. https://doi.org/10.1016/j.mayocp.2020.01.043.

51.

Vallabhajosyula S, Ya’Qoub L, Singh M, Bell MR, Gulati R, Cheungpasitporn W, et al. Sex disparities in the management and outcomes of cardiogenic shock complicating Acute myocardial infarction in the Young. Circ Heart Fail. 2020;13(10):e007154. https://doi.org/10.1161/circheartfailure.120.007154.CrossRefPubMedPubMedCentral

52.

Ya’qoub L, Lemor A, Dabbagh M, O’Neill W, Khandelwal A, Martinez SC, et al. Racial, ethnic, and sex disparities in patients with STEMI and cardiogenic shock. JACC: Cardiovasc Interventions. 2021;14(6):653–60. https://doi.org/10.1016/j.jcin.2021.01.003.CrossRef

53.

Wang AS, Nemeth S, Vinogradsky A, Kurlansky P, Brodie D, Fried J, et al. Disparities in the treatment of cardiogenic shock: does sex matter? Eur J Cardiothorac Surg. 2022;62(6). https://doi.org/10.1093/ejcts/ezac543.

54.

Ton VK, Kanwar MK, Li B, Blumer V, Li S, Zweck E, et al. Impact of female sex on cardiogenic shock outcomes: a cardiogenic shock Working Group Report. JACC Heart Fail. 2023. https://doi.org/10.1016/j.jchf.2023.09.025.CrossRefPubMed

55.

Joseph SM, Brisco MA, Colvin M, Grady KL, Walsh MN, Cook JL, et al. Women with cardiogenic shock derive Greater Benefit from early mechanical circulatory support: an Update from the cVAD Registry. J Interv Cardiol. 2016;29(3):248–56. https://doi.org/10.1111/joic.12298.CrossRefPubMed

56.

Isorni M-A, Aissaoui N, Angoulvant D, Bonello L, Lemesle G, Delmas C, et al. Temporal trends in clinical characteristics and management according to sex in patients with cardiogenic shock after acute myocardial infarction: the FAST-MI programme. Arch Cardiovasc Dis. 2018;111(10):555–63. https://doi.org/10.1016/j.acvd.2018.01.002.CrossRefPubMed

57.

Spaulding C, Racial. Ethnic, and sex disparities in cardiogenic shock due to STEMI: ACT NOW!∗. JACC: Cardiovasc Interventions. 2021;14(6):661–3. https://doi.org/10.1016/j.jcin.2021.01.039.CrossRef

58.

Vallabhajosyula S, Dunlay SM, Prasad A, Kashani K, Sakhuja A, Gersh BJ, et al. Acute Noncardiac Organ failure in Acute Myocardial Infarction with cardiogenic shock. J Am Coll Cardiol. 2019;73(14):1781–91. https://doi.org/10.1016/j.jacc.2019.01.053.CrossRefPubMed

59.

Raheja H, Waheed M, Harris C, Patel N, Hashmi A, Kundal S, et al. Racial disparities in the use of mechanical circulatory support devices in cardiogenic shock. Eur Heart J. 2021;42(Supplement1). https://doi.org/10.1093/eurheartj/ehab724.1484.

60.

Vallabhajosyula S, Dunlay SM, Barsness GW, Miller PE, Cheungpasitporn W, Stulak JM, et al. Sex disparities in the Use and outcomes of Temporary Mechanical Circulatory support for Acute myocardial infarction-cardiogenic shock. CJC open. 2020;2(6):462–72. https://doi.org/10.1016/j.cjco.2020.06.001.CrossRefPubMedPubMedCentral

61.

Patlolla SH, Shankar A, Sundaragiri PR, Cheungpasitporn W, Doshi RP, Vallabhajosyula S. Racial and ethnic disparities in the management and outcomes of cardiogenic shock complicating acute myocardial infarction. Am J Emerg Med. 2022;51:202–9. https://doi.org/10.1016/j.ajem.2021.10.051.CrossRefPubMed

62.

Vallabhajosyula S, Dunlay SM, Barsness GW, Rihal CS, Holmes DR Jr. Hospital-Level disparities in the outcomes of Acute Myocardial Infarction with cardiogenic shock. Am J Cardiol. 2019;124(4):491–8. https://doi.org/10.1016/j.amjcard.2019.05.038.CrossRefPubMed

63.

Vallabhajosyula S, Patlolla SH, Dunlay SM, Prasad A, Bell MR, Jaffe AS, et al. Regional Variation in the management and outcomes of Acute Myocardial Infarction with cardiogenic shock in the United States. Circ Heart Fail. 2020;13(2):e006661. https://doi.org/10.1161/circheartfailure.119.006661.CrossRefPubMedPubMedCentral

64.

Patlolla SH, Gilbert ON, Belford PM, Morris BN, Jentzer JC, Pisani BA, et al. Escalation strategies, management, and outcomes of acute myocardial infarction-cardiogenic shock patients receiving percutaneous left ventricular support. Catheter Cardiovasc Interv. 2023;102(3):403–14. https://doi.org/10.1002/ccd.30786.CrossRefPubMed

65.

Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, et al. A standardized and Comprehensive Approach to the management of cardiogenic shock. JACC Heart Fail. 2020;8(11):879–91. https://doi.org/10.1016/j.jchf.2020.09.005.CrossRefPubMedPubMedCentral

66.

Senman B, Jentzer JC, Barnett CF, Bartos JA, Berg DD, Chih S, et al. Need for a cardiogenic shock team collaborative-promoting a team-based model of care to improve outcomes and identify best practices. J Am Heart Assoc. 2024;13(6):e031979. https://doi.org/10.1161/jaha.123.031979.CrossRefPubMedPubMedCentral

67.

Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK Stage classification Expert Consensus Update: a review and incorporation of Validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), society of critical Care Medicine (SCCM), and Society of thoracic surgeons (STS) in December 2021. J Am Coll Cardiol. 2022;79(9):933–46. https://doi.org/10.1016/j.jacc.2022.01.018.CrossRefPubMed

68.

Rab T. Shock teams and shock docs. J Am Coll Cardiol. 2019;73(13):1670–2. https://doi.org/10.1016/j.jacc.2019.01.039.CrossRefPubMed

69.

Lee F, Hutson JH, Boodhwani M, McDonald B, So D, De Roock S, et al. Multidisciplinary Code Shock Team in cardiogenic shock: a Canadian centre experience. CJC open. 2020;2(4):249–57. https://doi.org/10.1016/j.cjco.2020.03.009.CrossRefPubMedPubMedCentral

70.

Moghaddam N, van Diepen S, So D, Lawler PR, Fordyce CB. Cardiogenic shock teams and centres: a contemporary review of multidisciplinary care for cardiogenic shock. ESC Heart Fail. 2021;8(2):988–98. https://doi.org/10.1002/ehf2.13180.CrossRefPubMedPubMedCentral

71.

Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, et al. Shock Team Approach in Refractory cardiogenic shock requiring short-term mechanical circulatory support: a proof of Concept. Circulation. 2019;140(1):98–100. https://doi.org/10.1161/circulationaha.119.040654.CrossRefPubMedPubMedCentral

72.

Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC, et al. Standardized team-based care for cardiogenic shock. J Am Coll Cardiol. 2019;73(13):1659–69. https://doi.org/10.1016/j.jacc.2018.12.084.CrossRefPubMed

73.

Vallabhajosyula SO, Jentzer A, Sinha JC, Kochar SS, Gerberi A, Mullin DJ, Ahn CJ, Sodha SH, Ventetuolo NR, Levine CE, Abbott DJ, Aliotta BG, Poppas JM, Abbott A. J.D. Multidisciplinary care teams in Acute Cardiovascular Care: a review of composition, Logistics, outcomes, training and future directions. J Card Fail. 2024;In Press.

74.

Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. 2018;91(3):454–61. https://doi.org/10.1002/ccd.27427.CrossRefPubMed

75.

Basir MB, Kapur NK, Patel K, Salam MA, Schreiber T, Kaki A, et al. Improved outcomes Associated with the use of shock protocols: updates from the National Cardiogenic Shock Initiative. Catheter Cardiovasc Interv. 2019;93(7):1173–83. https://doi.org/10.1002/ccd.28307.CrossRefPubMed

76.

Basir MB, Lemor A, Gorgis S, Patel KC, Kolski BC, Bharadwaj AS, et al. Early utilization of mechanical circulatory support in Acute myocardial infarction complicated by cardiogenic shock: the National Cardiogenic Shock Initiative. J Am Heart Assoc. 2023;12(23):e031401. https://doi.org/10.1161/jaha.123.031401.CrossRefPubMedPubMedCentral

77.

Mehta A, Vavilin I, Nguyen AH, Batchelor WB, Blumer V, Cilia L, et al. Contemporary approach to cardiogenic shock care: a state-of-the-art review. Front Cardiovasc Med. 2024;11:1354158. https://doi.org/10.3389/fcvm.2024.1354158.CrossRefPubMedPubMedCentral

78.

SCAI. Shock Quality Improvement Tool. https://scai.org/sites/default/files/2023-05/SCAI%20SHOCK%20QI%20Tool.pdf. (2023). Accessed.

79.

Vallabhajosyula S, Mehta A, Bansal M, Jentzer JC, Applefeld WN, Sinha SS, et al. Training paradigms in critical care cardiology: a scoping review of current literature. JACC Adv. 2024;3(3). https://doi.org/10.1016/j.jacadv.2024.100850.

80.

Tehrani BN, Sherwood MW, Rosner C, Truesdell AG, Ben Lee S, Damluji AA, et al. A standardized and Regionalized Network of Care for cardiogenic shock. JACC Heart Fail. 2022;10(10):768–81. https://doi.org/10.1016/j.jchf.2022.04.004.CrossRefPubMedPubMedCentral

81.

Rab T, Ratanapo S, Kern KB, Basir MB, McDaniel M, Meraj P, et al. Cardiac shock Care centers: JACC Review topic of the Week. J Am Coll Cardiol. 2018;72(16):1972–80. https://doi.org/10.1016/j.jacc.2018.07.074.CrossRefPubMed

82.

Alvarez Villela M, Fu D, Roslin K, Smoller R, Asemota D, Miklin DJ, et al. Defining levels of care in cardiogenic shock. Front Cardiovasc Med. 2023;10:1206570. https://doi.org/10.3389/fcvm.2023.1206570.CrossRefPubMedPubMedCentral

83.

Garan AR, Kataria R, Li B, Sinha S, Kanwar MK, Hernandez-Montfort J, et al. Outcomes of patients transferred to Tertiary Care centers for treatment of cardiogenic shock: a cardiogenic shock Working Group Analysis. J Card Fail. 2024;30(4):564–75. https://doi.org/10.1016/j.cardfail.2023.09.003.CrossRefPubMed

84.

Lu DY, Adelsheimer A, Chan K, Yeo I, Krishnan U, Karas MG, et al. Impact of hospital transfer to hubs on outcomes of cardiogenic shock in the real world. Eur J Heart Fail. 2021;23(11):1927–37. https://doi.org/10.1002/ejhf.2263.CrossRefPubMed

85.

Jentzer JC, Burstein B, Van Diepen S, Murphy J, Holmes DR Jr., Bell MR, et al. Defining shock and preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit patients. Circ Heart Fail. 2021;14(1):e007678. https://doi.org/10.1161/circheartfailure.120.007678.CrossRefPubMed

86.

van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary Management of cardiogenic shock: a Scientific Statement from the American Heart Association. Circulation. 2017;136(16):e232–68. https://doi.org/10.1161/cir.0000000000000525.CrossRefPubMed

87.

Jentzer JC, Bhat AG, Patlolla SH, Sinha SS, Miller PE, Lawler PR et al. Concomitant Sepsis diagnoses in Acute myocardial infarction-cardiogenic shock: 15-Year national temporal trends, Management, and outcomes. Crit Care Explorations. 2022;4(2).

88.

Vallabhajosyula S, Dunlay SM, Prasad A, Sangaralingham LR, Kashani K, Shah ND, et al. Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000–2017. Resuscitation. 2020;155:55–64. https://doi.org/10.1016/j.resuscitation.2020.07.022.CrossRefPubMed

89.

Vallabhajosyula S, Katz JN, Menon V. Quantification of Vasoactive Medications and the Pharmaco-Mechanical Continuum in cardiogenic shock. Circ Heart Fail. 2022;15(4):e008736. https://doi.org/10.1161/circheartfailure.121.008736.CrossRefPubMed

90.

Vallabhajosyula SA, Kapur JD. N.K. The Need to Define High-Dose Pharmacological Circulatory Support in Cardiogenic Shock. Mayo Clin Proc. 2024;In Press.

91.

Vallabhajosyula S, Jentzer JC, Kotecha AA, Murphree DH Jr., Barreto EF, Khanna AK, et al. Development and performance of a novel vasopressor-driven mortality prediction model in septic shock. Ann Intensive Care. 2018;8(1):112. https://doi.org/10.1186/s13613-018-0459-6.CrossRefPubMedPubMedCentral

92.

Jentzer JC, Wiley B, Bennett C, Murphree DH, Keegan MT, Kashani KB, et al. Temporal trends and Clinical outcomes Associated with Vasopressor and Inotrope Use in the Cardiac Intensive Care Unit. Shock. 2020;53(4):452–9. https://doi.org/10.1097/shk.0000000000001390.CrossRefPubMed

93.

Sato R, Duggal A, Sacha GL, Rudoni MA, Yataco AC, Khanna AK, et al. The Relationship between Norepinephrine Equivalent Dose of Vasopressors within 24 hours from the onset of septic shock and In-Hospital mortality rate. Chest. 2022. https://doi.org/10.1016/j.chest.2022.07.018.CrossRefPubMed

94.

Burstein B, Tabi M, Barsness GW, Bell MR, Kashani K, Jentzer JC. Association between mean arterial pressure during the first 24 hours and hospital mortality in patients with cardiogenic shock. Crit Care. 2020;24(1):513. https://doi.org/10.1186/s13054-020-03217-6.CrossRefPubMedPubMedCentral

95.

Burstein B, Vallabhajosyula S, Ternus B, Murphree D, Barsness GW, Kashani K, et al. Outcomes Associated with Norepinephrine Use among Cardiac Intensive Care Unit patients with severe shock. Shock. 2021;56(4):522–8. https://doi.org/10.1097/shk.0000000000001767.CrossRefPubMed

96.

Choi KH, Yang JH, Park TK, Lee JM, Song YB, Hahn JY, et al. Differential Prognostic implications of Vasoactive Inotropic score for patients with Acute myocardial infarction complicated by cardiogenic shock according to Use of Mechanical Circulatory support. Crit Care Med. 2021;49(5):770–80. https://doi.org/10.1097/ccm.0000000000004815.CrossRefPubMed

97.

Zweck E, Kanwar M, Li S, Sinha SS, Garan AR, Hernandez-Montfort J, et al. Clinical course of patients in cardiogenic shock stratified by phenotype. JACC Heart Fail. 2023;11(10):1304–15. https://doi.org/10.1016/j.jchf.2023.05.007.CrossRefPubMed

98.

Zweck E, Thayer KL, Helgestad OKL, Kanwar M, Ayouty M, Garan AR, et al. Phenotyping cardiogenic shock. J Am Heart Assoc. 2021;10(14):e020085. https://doi.org/10.1161/jaha.120.020085.CrossRefPubMedPubMedCentral

99.

Belur AD, Mehta A, Bansal M, Wieruszewski PM, Kataria R, Saad M, et al. Palliative care in the cardiovascular intensive care unit: a systematic review of current literature. Cardiovasc Revasc Med. 2024. https://doi.org/10.1016/j.carrev.2024.03.024.CrossRefPubMed

100.

Kanwar A, Patlolla SH, Singh M, Murphree DH, Sundaragiri PR, Jaber WA, et al. Temporal trends, predictors and outcomes of Inpatient Palliative Care Use in Cardiac arrest complicating Acute myocardial infarction. Resuscitation. 2021;170:53–62. https://doi.org/10.1016/j.resuscitation.2021.10.044.CrossRefPubMed

101.

Vallabhajosyula S, Prasad A, Dunlay SM, Murphree DH Jr., Ingram C, Mueller PS, et al. Utilization of Palliative Care for cardiogenic shock complicating Acute myocardial infarction: a 15-Year National Perspective on trends, disparities, predictors, and outcomes. J Am Heart Assoc. 2019;8(15):e011954. https://doi.org/10.1161/jaha.119.011954.CrossRefPubMedPubMedCentral

102.

103.

Brown SM, Lanspa MJ, Jones JP, Kuttler KG, Li Y, Carlson R, et al. Survival after shock requiring high-dose vasopressor therapy. Chest. 2013;143(3):664–71. https://doi.org/10.1378/chest.12-1106.CrossRefPubMed

Tehrani BN, Sherwood MW, Rosner C, Truesdell AG, Ben Lee S, Damluji AA, et al. A standardized and regionalized network of care for cardiogenic shock. JACC Heart Fail. 2022;10(10):768 − 81. Findings from this study lay the scaffold for team-based care in CS including regionalization of care to achieve optimal patient outcomes.

Ton VK, Kanwar MK, Li B, Blumer V, Li S, Zweck E, et al. Impact of female sex on cardiogenic shock outcomes: A Cardiogenic Shock Working Group report. JACC Heart Fail. 2023. doi: https://doi.org/10.1016/j.jchf.2023.09.025. Findings from this study highlight ongoing health care disparities in CS care (specific to sex disparities).

Vallabhajosyula S, Payne SR, Jentzer JC, Sangaralingham LR, Kashani K, Shah ND, et al. Use of post-acute care services and readmissions after acute myocardial infarction complicated by cardiac arrest and cardiogenic shock. Mayo Clin Proc Innov Qual Outcomes. 2021;5(2):320-9. Findings from this study elucidate the long-term impact of AMI-CS on the health care system including post-acute care resource utilization and readmissions in those with and without concomitant cardiac arrest.

Titel: The Price We Pay for Progression in Shock Care: Economic Burden, Accessibility, and Adoption of Shock-Teams and Mechanical Circulatory Support Devices
verfasst von: Saraschandra Vallabhajosyula
Shashank S. Sinha
Ajar Kochar
Mohit Pahuja
Frank J. Amico Jr
Navin K. Kapur
Publikationsdatum: 26.09.2024
Verlag: Springer US
Erschienen in: Current Cardiology Reports / Ausgabe 10/2024
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-024-02108-4

Current and Emerging Approaches for Primary Prevention of Coronary Artery Disease Using Cardiac Computed Tomography

Cardiac PET, CT, and MRI (P Cremer, Section Editor)

Chagas Disease: Epidemiology, Diagnosis, and Treatment

Heart Failure (HJ Eisen, Section Editor)

The Effect of Recurrent Heart Failure Hospitalizations on the Risk of Cardiovascular and all-Cause Mortality: a Systematic Review and Meta-Analysis

Heart Failure (HJ Eisen, Section Editor)

Going from Primary to Primordial Prevention: Is the Juice Worth the Squeeze?

Public Health Policy (SS Virani and D Mahtta, Section Editors)

Management of Ventricular Arrhythmias in Heart Failure: Can Less Be More?

Heart Failure (HJ Eisen, Section Editor)

Clinical Advances in Cardiovascular Computed Tomography: From Present Applications to Promising Developments

Open Access
Cardiac PET, CT, and MRI (P Cremer, Section Editor)

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Kardiologie

Lipidtherapie im Praxisalltag: Noch viel Spielraum für Verbesserung

25.04.2025
DGK-Jahrestagung 2025
Kongressbericht

Wie steht es um die Behandlung von Dyslipidämien bei Risikopatienten mit atherosklerotischer Gefäßerkrankung in Deutschland? Eine Bestandsaufnahme dazu liefert das bei der DGK-Tagung 2025 vorgestellte Forschungsprojekt LipidSnapshot.

Schützen GLP1-Rezeptor-Agonisten vor kardiovaskulären Komplikationen nach Pneumonie?

24.04.2025
DGP 2025
Kongressbericht

Kardiovaskuläre Ereignisse nach Lungeninfektionen sind häufig, doch pathophysiologisch wenig verstanden. Dass womöglich Glukagon daran Anteil hat, eröffnet neue therapeutische Perspektiven.

Beeinträchtigte Ventrikelfüllung erhöht die COPD-Mortalität

24.04.2025
COPD
Nachrichten

Patienten mit chronisch obstruktiver Lungenerkrankung und eingeschränkter Füllung der linken Herzkammer haben ein erhöhtes Sterberisiko. Dabei sind zwei Formen des Füllungsdefizits zu unterscheiden, wie eine Studie zeigt.

Auf dem Weg zur Präzisionsmedizin in der Kardiologie

23.04.2025
DGK-Jahrestagung 2025
Kongressbericht

Eine Entwicklung hin zur Präzisionsmedizin ist derzeit auch im Bereich der Kardiologie voll im Gang. Informationen zu den dabei inzwischen erzielten Fortschritten gab es bei der DGK-Jahrestagung 2025 in Mannheim.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The Price We Pay for Progression in Shock Care: Economic Burden, Accessibility, and Adoption of Shock-Teams and Mechanical Circulatory Support Devices

Abstract

Purpose of Review

Recent Findings

Summary

Weitere Artikel der Ausgabe 10/2024

Current and Emerging Approaches for Primary Prevention of Coronary Artery Disease Using Cardiac Computed Tomography

Chagas Disease: Epidemiology, Diagnosis, and Treatment

The Effect of Recurrent Heart Failure Hospitalizations on the Risk of Cardiovascular and all-Cause Mortality: a Systematic Review and Meta-Analysis

Going from Primary to Primordial Prevention: Is the Juice Worth the Squeeze?

Management of Ventricular Arrhythmias in Heart Failure: Can Less Be More?

Clinical Advances in Cardiovascular Computed Tomography: From Present Applications to Promising Developments

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Neu im Fachgebiet Kardiologie

Lipidtherapie im Praxisalltag: Noch viel Spielraum für Verbesserung

Schützen GLP1-Rezeptor-Agonisten vor kardiovaskulären Komplikationen nach Pneumonie?

Beeinträchtigte Ventrikelfüllung erhöht die COPD-Mortalität

Auf dem Weg zur Präzisionsmedizin in der Kardiologie

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

Update Kardiologie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten